Digital Clinical Safety in implementing chemotherapy regime in an e-prescribing platform
In the highly regulated and complex field of oncology, ensuring digital clinical safety when implementing medical oncology regimens within an e-prescribing platform is critical to maintaining the highest standards of patient care. I have previously partnered with a private comprehensive oncology centre to identify, evaluate, and mitigate potential safety risks that may arise during the digital transformation of oncology treatments.
From managing intricate chemotherapy dosing schedules to ensuring compliance with drug interaction protocols, my services focused on embedding clinical safety at the core of the digital solutions. This meant I provided these outcomes:
Participating in ACT-NOW working group (Te Aho o Te Kahu – Cancer Control Agency) who were working on standardising chemotherapy regimen across New Zealand to ensure the organisation’s protocol’s were in line with the international standard
Building a platform where unfunded medications and its use, procurement process and clinical safety was documented and updated
The end-to-end pathway of a chemotherapy patient was embedded into the electronic health record, including interactions with external vendors like a durg-compounding manufacturer.
Consulting clinicians to build optimal configuration for chemotherapy regimen into the e-prescribing SaaS product
Integrating advanced safety checks and controls within the e-prescribing system
Mitigating to reduce medication errors and support clinical decision-making
Building and testing optimal usability, clinical effectiveness and efficiency into the service design
Ensuring that your platform complies with relevant healthcare safety regulations and delivers a seamless and secure experience for both clinicians and patients
